Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,119 | -27,236 | -20,753 | -12,879 | -6,247 |
| Depreciation Amortization | 56 | 324 | 265 | 194 | 101 |
| Accounts receivable | -295 | -1,863 | -1,237 | 2 | 234 |
| Accounts payable and accrued liabilities | 396 | 164 | 447 | 340 | 95 |
| Other Working Capital | -238 | -198 | -50 | 298 | 373 |
| Other Operating Activity | 753 | 4,194 | 2,586 | 671 | 12 |
| Operating Cash Flow | $-7,447 | $-24,615 | $-18,742 | $-11,374 | $-5,432 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,785 | -21,910 | -26,945 | -20,770 | -25,340 |
| PPE Investments | -83 | -619 | -428 | -317 | -271 |
| Investing Cash Flow | $4,702 | $-22,529 | $-27,373 | $-21,087 | $-25,611 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 688 | 12,213 | 11,529 | 11,647 | 96 |
| Financing Cash Flow | $688 | $12,213 | $11,529 | $11,647 | $96 |
| Beginning Cash Position | 12,817 | 47,748 | 47,748 | 47,748 | 47,748 |
| End Cash Position | 10,760 | 12,817 | 13,162 | 26,934 | 16,801 |
| Net Cash Flow | $-2,057 | $-34,931 | $-34,586 | $-20,814 | $-30,947 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,447 | -24,615 | -18,742 | -11,374 | -5,432 |
| Capital Expenditure | -83 | -619 | -428 | -317 | -271 |
| Free Cash Flow | -7,530 | -25,234 | -19,170 | -11,691 | -5,703 |